The term recombinant refers to any form that is produced by a DNA sequence other than the natural form. This is different from genetic in that the genetic material is identical from one person to another and therefore can be passed on genetically. In most cases, the term genetic refers to the process that takes place when the somatic cells are implanted in embryos. There are many uses for recombinant human endostatin and it is often used in the treatment of many severe diseases. The word medical in recombinant human endostatin is important as it indicates that only cells can be used in medical applications. Therefore, it cannot be used as an in vitro fertilization (IVF) procedure where sperm cells are used.
The goal of any recombinant human endostatin study is to provide a database of all such tissue compositions at a single site. This database will allow for easy comparison of the compositions between cells using different types of tissues at one single site. In addition to comparisons between cells, the database will also allow for comparisons between different organ systems. For instance, there is a requirement for inclusion criteria that cells are grown in the GI tract and there are plans to include a shot of digestive tract biopsy material.
There is also a plan to include a layout table so that researchers can evaluate the different combinations of biopsies for each patient. Biotechnological developers typically concentrate their efforts on the development of drugs for a single disease and often fail to realize the importance of optimizing their drugs for use in other diseases as well. Biotechnological companies that rely solely on the development of angiogenesis agents for the treatment of cancers may not have the financial resources to develop more effective compounds to replace the failed drugs
No comments:
Post a Comment